Hybridization-based design of novel anticholinesterase indanone-carbamates for Alzheimer's disease: Synthesis, biological evaluation, and docking studies
Hybridization-based design of novel anticholinesterase indanone-carbamates for Alzheimer's disease: Synthesis, biological evaluation, and docking studies
نویسندگان: محمد شهریور گرگری , مریم حمزه میوه رود , سالار همتی , جاوید شهبازی , سیاوش دستمالچی
کلمات کلیدی: acetylcholinesterase inhibitor, Alzheimer's disease, amyloid‐β self‐aggregation,
indanone–carbamate hybrid, partial noncompetitive mixed‐type inhibition
نشریه: 3035 , 7 , 354 , 2021
| نویسنده ثبت کننده مقاله |
سیاوش دستمالچی |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز تحقیقات بیوتکنولوژی(زیست فناوری) |
| کد مقاله |
77678 |
| عنوان فارسی مقاله |
Hybridization-based design of novel anticholinesterase indanone-carbamates for Alzheimer's disease: Synthesis, biological evaluation, and docking studies |
| عنوان لاتین مقاله |
Hybridization-based design of novel anticholinesterase indanone-carbamates for Alzheimer's disease: Synthesis, biological evaluation, and docking studies |
| ناشر |
7 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Inspired by the structures of donepezil and rivastigmine, a novel series of
indanone–carbamate hybrids was synthesized using the pharmacophore
hybridization‐based design strategy, and their biological activities toward acetylcholinesterase (AChE) and butyrylcholinesterase were evaluated. Among the
synthesized compounds, 4d and 4b showed the highest AChE inhibitory activities
with IC50 values in the micromolar range (compound 4d: IC50 = 3.04 μM; compound
4b: IC50 = 4.64 μM). Moreover, the results of the Aβ1–40 aggregation assay revealed
that compound 4b is a potent Aβ1–40 aggregation inhibitor. The kinetics of AChE
enzymatic activity in the presence of 4b was investigated, and the results were
indicative of a reversible partial noncompetitive type of inhibition. A molecular
docking study was conducted to determine the possible allosteric binding mode of
4b with the enzyme. The allosteric nature of AChE inhibition by these compounds
provides the opportunity for the design of subtype‐selective enzyme inhibitors. The
presented indanone–carbamate scaffold can be structurally modified and optimized
through medicinal chemistry‐based approaches for designing novel multitargeted
anti‐Alzheimer agents |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| second paper PhD course.pdf | 1400/10/04 | 2693930 | دانلود |